Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Mechanism of Smoldering Disease

Between The Lines: GVHD, Episode 1 – Understanding the Foundation of Graft vs Host Disease

Disease Progression Monitoring

EoETaly Guidelines Part-2

BTK Enzyme

Disease Overview

Smoldering Disease Detection

Smoldering Disease Burden

EoETaly Guidelines Part-1

Tolebrutinib Direct Effects on Myeloid Cells in PwMS

Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity

Inside MS: Explore how BTK drives immune cell activation and CNS damage